Europe Pulmonary Function Testing Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2024 –2031 |
 시장 규모(기준 연도) |
USD 997.65 Million |
 시장 규모(예측 연도) |
USD 1,522.79 Million |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
>유럽 폐 기능 검사 시장, 유형별(하드웨어, 서비스 및 소프트웨어), 환자 유형(소아, 성인 및 노인), 응용 분야(폐쇄성 폐 질환 및 제한성 폐 질환), 최종 사용자(병원, 전문 클리닉, 진단 실험실, 가정 간병 시설 및 기타) - 업계 동향 및 2031년까지의 전망.
유럽 폐기능 검사 시장 분석 및 통찰력
폐 기능 검사 시장은 호흡기 질환의 유병률 증가, 기술 발전, 개인화된 의학에 대한 수요 증가에 의해 주도되고 있습니다. 시장의 주요 추세로는 진료 시점 PFT 장치 채택 증가, 무선 및 휴대용 PFT 장치에 대한 수요 증가, 개인화된 의학 및 정밀 의학 에 대한 집중 증가 가 있습니다. 그러나 시장은 일부 지역에서 PFT 장치에 대한 접근성 제한, PFT 장치 및 소모품의 높은 비용, PFT 해석 및 분석의 복잡성, 의료 제공자와 환자 사이에서 PFT에 대한 인식 부족과 같은 과제에도 직면해 있습니다.
Data Bridge Market Research에 따르면 유럽 폐기능 검사 시장은 2023년 9억 9,765만 달러에서 2031년 1,522.79만 달러로 성장할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률 5.5%로 성장할 것으로 예상됩니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2024년부터 2031년까지 |
|
기준 연도 |
2023 |
|
역사적 연도 |
2022 (2016-2021년까지 사용자 정의 가능) |
|
양적 단위 |
수익 (단위: USD 백만) |
|
다루는 세그먼트 |
유형(하드웨어, 서비스 및 소프트웨어), 환자 유형(소아, 성인 및 노인), 애플리케이션(폐쇄성 폐질환 및 제한성 폐질환), 최종 사용자(병원, 전문 클리닉, 진단 연구소, 가정 간병 시설 및 기타) |
|
적용 국가 |
독일, 이탈리아, 영국, 프랑스, 스위스, 스페인, 러시아, 터키, 벨기에, 네덜란드, 스웨덴, 덴마크, 노르웨이, 핀란드, 폴란드 및 기타 유럽 국가 |
|
시장 참여자 포함 |
VYAIRE MEDICAL, INC., Teleflex Incorporated, CAIRE, Inc., COSMED srl, Schiller AG, Ganshorn Medizin Electronic GmbH, ndd Medical Technologies, KoKo PFT, GERATHERM MEDICAL AG, ECO MEDICS, SIBEL, SAU, Clarity Medical, Data Sciences International, MEC, Scireq, MEDLINE, Recorders and Medicare Systems, VITALOGRAPH, medical equipment europe GMBH, CHEST MI, Inc., CONTEC MEDICAL SYSTEMS CO., LTD 등 |
시장 정의
폐 기능 검사(PFT)는 만성 폐쇄성 폐 질환(COPD), 천식, 만성 기관지염 과 같은 호흡기 질환을 진단하고 모니터링하는 데 사용되는 폐 기능의 포괄적인 평가입니다 . PFT의 시장 정의에는 강제적 생명력(FVC), 강제적 호기량(FEV1), FEV1/FVC 비율, 최대 자발적 환기(MVV), 확산 용량(DLCO)을 포함한 다양한 검사가 포함됩니다. PFT는 일반적으로 환자가 흡입하고 호기하는 공기의 양과 흐름을 측정하는 장치인 스피로미터를 사용하여 수행됩니다.
유럽 폐기능 검사 시장 동향
이 섹션에서는 시장 동인, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.
운전자
- 호흡기 질환의 유병률 증가
호흡기 질환의 유병률 증가는 글로벌 폐 기능 검사 시장의 중요한 원동력입니다. 만성 폐쇄성 폐 질환(COPD) 및 천식과 같은 질환은 인구 고령화, 환경 오염 물질 및 라이프스타일 변화와 같은 요인으로 인해 점점 더 흔해지고 있습니다. 이러한 질환의 유병률이 증가함에 따라 이러한 질환을 관리하고 모니터링하기 위한 정확하고 신뢰할 수 있는 진단 도구에 대한 수요가 높아지고 있습니다. 폐 기능 검사는 호흡기 질환을 진단하고, 심각도를 평가하고, 질병 진행을 추적하는 데 필수적입니다. 정기적이고 정확한 검사에 대한 이러한 증가된 수요는 의료 서비스 제공자와 환자가 호흡기 건강 결과를 개선하고 효과적인 관리 전략을 제공하기 위해 고급 PFT 기술을 찾고 있기 때문에 시장을 주도하고 있습니다.
- 호흡기 질환의 조기 발견
조기 발견의 호흡기 질환 증가는 글로벌 폐 기능 검사(PFT) 시장의 주요 원동력입니다. 천식, 만성 폐쇄성 폐 질환(COPD), 낭포성 섬유증과 같은 호흡기 질환의 급증은 폐 기능 검사에 대한 수요를 촉진합니다. 폐 기능 검사는 호흡기 질환의 조기 발견과 효율적인 관리를 가능하게 하는 데 중요한 역할을 하며, 이를 통해 시기적절한 개입과 치료를 통해 환자의 결과와 삶의 질을 개선합니다.
기회
- 급속한 기술 발전
특히 AI와 통합된 혁신적인 PFT 장치의 개발은 진단 정확도와 효율성을 향상시켜 폐 질환을 식별하는 데 더욱 신뢰할 수 있는 결과를 제공합니다. 포괄적인 검사 시스템은 점점 더 사용자 친화적이고 휴대성이 높아져 더 광범위한 의료 환경에서 사용할 수 있습니다. AI 및 원격 진료와 같은 디지털 건강 기술과의 통합은 고급 진단 정확도와 예측 분석, 연결된 PFT 장치를 통한 원격 모니터링을 가능하게 하여 이러한 도구의 도달 범위와 영향을 확대합니다. 고감도 및 웨어러블 센서를 포함한 고급 센서 기술은 지속적인 모니터링과 실시간 데이터 수집을 제공하여 보다 정확하고 시기적절한 개입을 가능하게 합니다.
도전/ 제약
- 테스트 장비의 높은 비용
폐 기능 검사 장비의 높은 비용은 소규모 의료 시설의 접근을 제한하고 특정 지역의 침투를 방해하여 시장 성장을 저해합니다. 정교한 PFT 장치를 구매하고 유지하는 데 필요한 상당한 투자는 특히 개발 도상 지역의 의료 시설에 재정적 어려움을 안겨줍니다. 이러한 경제적 장벽은 PFT 기술의 광범위한 채택과 사용을 제한하여 전체 시장 성장과 접근성에 영향을 미칩니다. 이러한 비용 문제를 해결하는 것은 전 세계적으로 폐 기능 검사의 도달 범위와 영향을 향상시키는 데 필수적입니다.
- 표준화 부족 및 테스트 결과의 다양성
균일한 표준이 현저히 부족하면 장치 사양과 테스트 프로토콜이 다양해져 다양한 장비에서 테스트 결과의 일관성과 비교성을 저해할 수 있습니다. 이러한 다양성은 PFT 장치를 전자 건강 기록(EHR) 시스템에 통합하려는 노력을 복잡하게 만들어 원활한 데이터 교환과 포괄적인 환자 기록을 달성하기 어렵게 만듭니다. 표준화된 프로토콜이 없으면 다양한 PFT 장치의 데이터를 정확하고 효율적으로 EHR 시스템에 통합할 수 있도록 하는 것은 여전히 복잡한 작업입니다.
최근 개발
- 2024년 4월, Clario가 ArtiQ를 인수하면서 고급 AI 기능을 통합하여 호흡기 솔루션 포트폴리오가 강화되었습니다. 이 전략적 움직임은 Clario의 전문성과 ArtiQ의 혁신적인 기술을 결합하여 임상 시험에서 테스트 품질을 개선하고 데이터 처리를 가속화합니다. Inofab Health와 함께 이 인수를 통해 Clario는 호흡기 치료 분야에서 리더십을 공고히 하고 AI 기반 임상 솔루션을 확대합니다.
- 2023년 9월, PulmOne은 중국에서 MiniBox+를 출시하여 유통업체 HTDK를 통해 2023년 중국 흉부학회(CTS) 연례 의회에서 폐의학자들에게 선보였습니다. 소개는 참석자들로부터 큰 열광을 받았습니다. 이벤트의 흥미로운 비디오 하이라이트를 확인하세요.
- 2023년 5월, Geratherm Medical AG는 튀링겐주 개발 공사(LEG)로부터 "숨겨진 챔피언"으로 선정되었습니다. 이 인정은 의료 기술 분야에서 회사의 중요한 역할과 글로벌 시장 입지를 강조합니다. 이사회 멤버인 Christian Frick은 이 찬사에 감사를 표하며, 회사의 의료 진단, 폐 기능 측정, 뇌졸중 예방 및 인큐베이터 시스템 혁신을 언급했습니다. 이는 회사의 미래 성장을 위한 좋은 위치입니다.
- 2023년 5월, 호흡기 진단 분야의 선두주자인 Vitalograph는 ATS 국제 컨퍼런스에서 Vitalograph tremoflo C-100 Oscillometer를 출시하면서 포트폴리오를 확장했습니다. Thorasys와 협력하여 개발된 이 혁신적인 장치는 간단한 조석 호흡을 통해 경미한 기도 손상을 감지하여 천식과 만성 폐쇄성 폐질환의 진단을 향상시킵니다. tremoflo C-100은 Vitalograph Spirotrac 플랫폼과 통합되어 호흡기 건강에 대한 포괄적인 관점을 제공하고 다양한 환경에서 정확하고 휴대 가능한 검사를 지원합니다.
- 2023년 4월, Ingmar Medical은 RespiSim 소프트웨어 버전 4.3을 출시했습니다. 이는 개선된 시나리오 가져오기/내보내기, 감소된 시뮬레이션 지연, 향상된 플랫폼 안정성을 포함한 주요 발전 사항입니다. 이러한 업데이트는 사용성과 성능을 크게 높여 호흡 요법 교육 및 훈련에 필수적인 도구가 되었습니다.
- 2022년 9월, IngMar Medical은 저렴하고 현실적인 환기 훈련을 제공하는 구독 기반 플랫폼인 RespiSim eLearning을 출시합니다. 가상 인공호흡기와 Cleveland Clinic 과정 모음을 특징으로 하는 이 새로운 제공은 하이브리드 및 원격 교육을 지원하여 환자 결과 향상에 전념하는 교육자 커뮤니티를 육성합니다.
유럽 폐기능 검사 시장 범위
유럽 폐 기능 검사 시장은 유형, 환자 유형, 응용 프로그램 및 최종 사용자를 기준으로 네 가지 주요 세그먼트로 세분화됩니다. 세그먼트 간의 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
유형
- 하드웨어
- 소프트웨어
- 서비스
유럽 폐기능 검사 시장은 서비스를 기준으로 하드웨어, 소프트웨어, 서비스로 구분됩니다.
환자 유형
- 성인
- 노인
- 소아과
유럽 폐기능 검사 시장은 환자 유형을 기준으로 성인, 노인, 소아로 구분됩니다.
애플리케이션
- 폐쇄성 폐질환
- 제한성 폐질환
유럽 폐기능 검사 시장은 적용 분야를 기준으로 폐쇄성 폐질환과 제한성 폐질환으로 구분됩니다.
최종 사용자
- 병원
- 전문 클리닉
- 진단 연구소
- 홈 케어 설정
- 기타
유럽 폐기능 검사 시장은 최종 사용자를 기준으로 병원, 전문 클리닉, 진단 실험실, 가정 간병 시설 및 기타로 구분됩니다.
유럽 폐기능 검사 시장 지역 분석/통찰력
유럽 폐기능 검사 시장은 유형, 환자 유형, 응용 분야, 최종 사용자를 기준으로 4개의 주요 부문으로 구분됩니다.
이 시장 보고서에서 다루는 국가는 독일, 이탈리아, 영국, 프랑스, 스위스, 스페인, 러시아, 터키, 벨기에, 네덜란드, 스웨덴, 덴마크, 노르웨이, 핀란드, 폴란드 및 기타 유럽 국가입니다.
독일은 제품 출시 증가와 홈 테스트 장비 등장으로 인해 유럽 지역 시장을 장악할 것으로 예상됩니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 대형 서비스 회사의 존재 및 가용성과 지역 및 국내 플레이어와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제와 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 유럽 폐기능 검사 시장 점유율 분석
유럽 폐기능 검사 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 승인, 제품 폭과 범위, 응용 프로그램 우세, 제품 유형 수명선 곡선입니다. 제공된 위의 데이터 포인트는 회사가 시장에 집중하는 것과만 관련이 있습니다.
의료 영상 시장에서 활동하는 주요 기업으로는 VYAIRE MEDICAL, INC., Teleflex Incorporated, CAIRE, Inc., COSMED srl, Schiller AG, Ganshorn Medizin Electronic GmbH, ndd Medical Technologies, KoKo PFT, GERATHERM MEDICAL AG, ECO MEDICS, SIBEL, SAU, Clarity Medical, Data Sciences International, MEC, Scireq, MEDLINE, Recorders and Medicare Systems, VITALOGRAPH, medical equipment europe GMBH, CHEST MI, Inc., CONTEC MEDICAL SYSTEMS CO., LTD 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE PULMONARY FUNCTION TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
5 REGULATORY FRAMEWORK
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF RESPIRATORY DISEASES
6.1.2 EARLY DETECTION OF RESPIRATORY DISEASES
6.1.3 GROWING GERIATRIC POPULATION
6.1.4 INCREASING PRODUCT LAUNCHES AND EMERGENCE OF HOME TESTING DEVICES
6.2 RESTRAINTS
6.2.1 HIGH COST OF TESTING EQUIPMENT
6.2.2 TECHNOLOGICAL LIMITATION OF TESTING DEVICES
6.3 OPPORTUNITIES
6.3.1 RAPID TECHNOLOGICAL ADVANCEMENTS
6.3.2 RISING STRATEGIC INITIATIVES
6.3.3 GOVERNMENT INITIATIVES AND REIMBURSEMENT POLICIES
6.3.4 PRODUCT DEVELOPMENT FOR AT-HOME TESTING
6.4 CHALLENGES
6.4.1 LACK OF STANDARDIZATION AND VARIABILITY IN TEST RESULTS
6.4.2 LACK OF SKILLED PROFESSIONALS
7 EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE
7.1 OVERVIEW
7.2 HARDWARE
7.2.1 PFT DEVICES
7.2.2 PFT ACCESSORIES & CONSUMABLES
7.2.2.1 Spirometry
7.2.2.2 Lung Volume in Unit/ Plethysmography Test
7.2.2.3 Gas Exchange Testing
7.2.2.4 Cardiopulmonary Exercise Test (CPET)
7.2.2.5 Pulse Oximetry Test
7.2.2.6 Diffusion Capacity Test
7.2.2.7 Maximal Voluntary Ventilation
7.2.2.8 Oxygen Titration Test
7.2.2.9 Respiratory Muscle Function
7.2.2.10 Bronchial Provocation Test
7.2.2.11 High Altitude Simulation Testing
7.2.3 OTHERS
7.2.3.1 3.2. Direct Tender
7.2.3.2 3.2. Retail Sales
7.2.4 OTHERS
7.3 SOFTWARE
7.4 SERVICES
8 EUROPE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE
8.1 OVERVIEW
8.2 ADULT
8.2.1 MALE
8.2.2 FEMALE
8.3 GERIATRIC
8.3.1 MALE
8.3.2 FEMALE
8.4 PEDIATRIC
8.4.1 MALE
8.4.2 FEMALE
9 EUROPE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 OBSTRUCTIVE LUNG DISEASE
9.2.1 ASTHMA
9.2.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
9.2.3 BRONCHIECTASIS
9.2.4 CYSTIC FIBROSIS
9.3 RESTRICTIVE LUNG DISEASE
9.3.1 LUNG CANCER
9.3.2 INTERSTITIAL LUNG DISEASE
9.3.3 AMYOTROPHIC LATERAL SCLEROSIS (ALS)
9.3.4 SCOLIOSIS
9.3.5 SARCOIDOSIS
9.3.6 MUSCULAR DYSTROPHY
10 EUROPE PULMONARY FUNCTION TESTING MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 PUBLIC
10.2.2 PRIVATE
10.3 SPECIALTY CLINICS
10.4 DIAGNOSTICS LABORATORIES
10.5 HOME CARE SETTINGS
10.6 OTHERS
11 EUROPE PULMONARY FUNCTION TESTING MARKET, BY REGION
11.1 EUROPE
11.1.1 GERMANY
11.1.2 U.K.
11.1.3 FRANCE
11.1.4 FRANCE
11.1.5 ITALY
11.1.6 TURKEY
11.1.7 RUSSIA
11.1.8 SWITZERLAND
11.1.9 NETHERLANDS
11.1.10 SWEDEN
11.1.11 BELGIUM
11.1.12 DENMARK
11.1.13 NORWAY
11.1.14 FINLAND
11.1.15 POLAND
11.1.16 REST OF EUROPE
12 EUROPE PULMONARY FUNCTION TESTING MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 SWOT ANALYSIS
14 COMPANY PROFILES
14.1 VYAIRE MEDICAL, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 COMPANY SHARE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 TELEFLEX INCORPORATED
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO 258
14.2.5 RECENT DEVELOPMENT 258
14.3 CAIRE INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 COMPANY SHARE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENTS
14.4 COSMED SRL
14.4.1 COMPANY SNAPSHOT
14.4.2 COMPANY SHARE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 SCHILLER AG
14.5.1 COMPANY SNAPSHOT
14.5.2 COMPANY SHARE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENTS
14.6 CHEST M.I., INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 CLARITY MEDICAL
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 CONTEC MEDICAL SYSTEMS CO., LTD
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 DATA SCIENCES INTERNATIONAL.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 ECO MEDICS
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 FUKUDA SANGYO CO., LTD.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 GANSHORN MEDIZIN ELECTRONIC GMBH
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 GERATHERM MEDICAL AG
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENT
14.14 INGMAR MEDICAL
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 INOFAB HEALTH (A CLARIO COMPANY)
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 JK MEDICAL SYSTEMS PVT LTD.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 KOKO, PFT
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENTS
14.18 MEC
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENT
14.19 MEDICAL EQUIPMENT EUROPE GMBH
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 MEDLINE
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 MORGAN SCIENTIFIC
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENTS
14.22 NDD MEDICAL TECHNOLOGIES
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENTS
14.23 PULMONE ADVANCED MEDICAL DEVICES
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENT
14.24 RECORDERS & MEDICARE SYSTEMS PRIVATE LIMITED
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT
14.25 SCIREQ
14.25.1 COMPANY SNAPSHOT
14.25.2 PRODUCT PORTFOLIO
14.25.3 RECENT DEVELOPMENT
14.26 SIBEL, S.A.U
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENT
14.27 VITALOGRAPH
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
표 목록
TABLE 1 EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 2 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 3 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 4 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 5 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)
TABLE 6 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 7 EUROPE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 8 EUROPE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)
TABLE 9 EUROPE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 10 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 11 EUROPE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 12 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 13 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 15 EUROPE SOFTWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 16 EUROPE SERVICES IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 EUROPE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 18 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 19 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 20 EUROPE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 EUROPE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 22 EUROPE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 23 EUROPE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 24 EUROPE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 25 EUROPE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 26 EUROPE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 27 EUROPE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 EUROPE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 29 EUROPE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 30 EUROPE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 31 EUROPE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 32 EUROPE SPECIALTY CLINICS IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 33 EUROPE DIAGNOSTICS LABORATORIES IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 34 EUROPE HOME CARE SETTINGS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 35 EUROPE OTHERS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 36 EUROPE PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 37 EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 38 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 40 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 41 EUROPE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 42 EUROPE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 43 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 44 EUROPE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 45 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 46 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 47 EUROPE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 48 EUROPE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 49 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 50 EUROPE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 51 EUROPE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 52 EUROPE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 53 EUROPE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 54 EUROPE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 55 EUROPE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 56 EUROPE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 GERMANY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 58 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 GERMANY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 GERMANY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 61 GERMANY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 GERMANY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 63 GERMANY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 64 GERMANY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 65 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 66 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 67 GERMANY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 68 GERMANY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 GERMANY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 70 GERMANY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 71 GERMANY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 72 GERMANY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 73 GERMANY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 74 GERMANY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 GERMANY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 76 GERMANY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 77 U.K. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 78 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 79 U.K. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 80 U.K. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 81 U.K. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 82 U.K. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 83 U.K. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 84 U.K. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 85 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 86 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 87 U.K. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 88 U.K. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 89 U.K. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 90 U.K. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 91 U.K. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 92 U.K. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 93 U.K. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 94 U.K. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 U.K. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 96 U.K. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 97 FRANCE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 98 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 99 FRANCE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 100 FRANCE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 101 FRANCE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 102 FRANCE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 103 FRANCE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 104 FRANCE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 105 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 106 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 107 FRANCE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 108 FRANCE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 FRANCE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 110 FRANCE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 111 FRANCE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 112 FRANCE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 113 FRANCE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 114 FRANCE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 115 FRANCE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 116 FRANCE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 117 SPAIN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 118 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 119 SPAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 SPAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 121 SPAIN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 122 SPAIN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 123 SPAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 124 SPAIN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 125 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 126 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 127 SPAIN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 128 SPAIN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 129 SPAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 130 SPAIN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 131 SPAIN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 132 SPAIN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 133 SPAIN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 134 SPAIN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 135 SPAIN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 136 SPAIN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 137 ITALY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 138 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 139 ITALY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 140 ITALY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 141 ITALY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 142 ITALY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 143 ITALY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 144 ITALY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 146 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 147 ITALY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 148 ITALY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 149 ITALY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 150 ITALY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 151 ITALY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 152 ITALY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 153 ITALY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 154 ITALY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 155 ITALY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 156 ITALY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 157 TURKEY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 158 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 TURKEY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 160 TURKEY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 161 TURKEY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 162 TURKEY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 163 TURKEY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 164 TURKEY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 165 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 166 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 167 TURKEY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 TURKEY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 169 TURKEY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 170 TURKEY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 171 TURKEY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 172 TURKEY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 173 TURKEY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 174 TURKEY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 175 TURKEY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 176 TURKEY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 178 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 179 RUSSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 180 RUSSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 181 RUSSIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 182 RUSSIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 RUSSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 184 RUSSIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 185 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 186 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 187 RUSSIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 188 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 189 RUSSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 190 RUSSIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 191 RUSSIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 192 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 193 RUSSIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 194 RUSSIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 195 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 196 RUSSIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 197 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 198 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 199 SWITZERLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 200 SWITZERLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 201 SWITZERLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 202 SWITZERLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 203 SWITZERLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 204 SWITZERLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 205 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 206 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 207 SWITZERLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 208 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 209 SWITZERLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 210 SWITZERLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 211 SWITZERLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 212 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 213 SWITZERLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 214 SWITZERLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 215 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 216 SWITZERLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 217 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 218 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 219 NETHERLANDS PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 220 NETHERLANDS PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 221 NETHERLANDS PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 222 NETHERLANDS MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 223 NETHERLANDS ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 224 NETHERLANDS NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 225 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 226 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 227 NETHERLANDS RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 228 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 229 NETHERLANDS ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 230 NETHERLANDS GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 231 NETHERLANDS PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 232 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 233 NETHERLANDS OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 234 NETHERLANDS RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 235 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 236 NETHERLANDS HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 237 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 238 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 239 SWEDEN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 240 SWEDEN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 241 SWEDEN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 242 SWEDEN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 243 SWEDEN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 244 SWEDEN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 245 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 246 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 247 SWEDEN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 248 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 249 SWEDEN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 250 SWEDEN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 251 SWEDEN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 252 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 253 SWEDEN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 254 SWEDEN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 255 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 256 SWEDEN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 257 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 258 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 259 BELGIUM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 260 BELGIUM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 261 BELGIUM PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 262 BELGIUM MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 263 BELGIUM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 264 BELGIUM NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 265 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 266 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 267 BELGIUM RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 268 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 269 BELGIUM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 270 BELGIUM GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 271 BELGIUM PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 272 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 273 BELGIUM OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 274 BELGIUM RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 275 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 276 BELGIUM HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 277 DENMARK PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 278 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 279 DENMARK PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 280 DENMARK PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 281 DENMARK PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 282 DENMARK MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 283 DENMARK ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 284 DENMARK NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 285 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 286 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 287 DENMARK RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 288 DENMARK PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 289 DENMARK ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 290 DENMARK GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 291 DENMARK PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 292 DENMARK PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 293 DENMARK OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 294 DENMARK RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 295 DENMARK PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 296 DENMARK HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 297 NORWAY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 298 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 299 NORWAY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 300 NORWAY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 301 NORWAY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 302 NORWAY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 303 NORWAY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 304 NORWAY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 305 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 306 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 307 NORWAY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 308 NORWAY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 309 NORWAY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 310 NORWAY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 311 NORWAY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 312 NORWAY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 313 NORWAY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 314 NORWAY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 315 NORWAY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 316 NORWAY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 317 FINLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 318 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 319 FINLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 320 FINLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 321 FINLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 322 FINLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 323 FINLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 324 FINLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 325 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 326 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 327 FINLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 328 FINLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 329 FINLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 330 FINLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 331 FINLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 332 FINLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 333 FINLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 334 FINLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 335 FINLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 336 FINLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 337 POLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 338 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 339 POLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 340 POLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 341 POLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 342 POLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 343 POLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 344 POLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 345 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 346 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 347 POLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 348 POLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 349 POLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 350 POLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 351 POLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 352 POLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 353 POLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 354 POLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 355 POLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 356 POLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 357 REST OF EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
그림 목록
FIGURE 1 EUROPE PULMONARY FUNCTION TESTING MARKET: SEGMENTATION
FIGURE 2 EUROPE PULMONARY FUNCTION TESTING MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE PULMONARY FUNCTION TESTING MARKET: DROC ANALYSIS
FIGURE 4 EUROPE PULMONARY FUNCTION TESTING MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE PULMONARY FUNCTION TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE PULMONARY FUNCTION TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE PULMONARY FUNCTION TESTING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 EUROPE PULMONARY FUNCTION TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE PULMONARY FUNCTION TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE PULMONARY FUNCTION TESTING MARKET: SEGMENTATION
FIGURE 11 EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 INCREASING PREVALENCE OF RESPIRATORY DISEASES IS DRIVING THE GROWTH OF THE EUROPE PULMONARY FUNCTION TESTING MARKET FROM 2024 TO 2031
FIGURE 15 THE HARDWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE PULMONARY FUNCTION TESTING MARKET IN 2024 AND 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 EUROPE PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2023
FIGURE 18 EUROPE PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 19 EUROPE PULMONARY FUNCTION TESTING MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 20 EUROPE PULMONARY FUNCTION TESTING MARKET: BY TYPE, LIFELINE CURVE
FIGURE 21 EUROPE PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2023
FIGURE 22 EUROPE PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 23 EUROPE PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, CAGR (2024-2031)
FIGURE 24 EUROPE PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 25 EUROPE PULMONARY FUNCTION TESTING MARKET: BY APPLICATION 2023
FIGURE 26 EUROPE PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 27 EUROPE PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 28 EUROPE PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 29 EUROPE PULMONARY FUNCTION TESTING MARKET: BY END USER 2023
FIGURE 30 EUROPE PULMONARY FUNCTION TESTING MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 31 EUROPE PULMONARY FUNCTION TESTING MARKET: END USER, CAGR (2024-2031)
FIGURE 32 EUROPE PULMONARY FUNCTION TESTING MARKET: END USER, LIFELINE CURVE
FIGURE 33 EUROPE PULMONARY FUNCTION TESTING MARKET: SNAPSHOT (2023)
FIGURE 34 EUROPE PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
